Hybrid non-viral and viral delivery strategy achieves potent gene editing in growing livers with reduced viral dosage
Molecular Therapy · 2024
DOI: 10.1016/j.ymthe.2024.08.021 ↗Kurz gefasst
Kommentar in der Zeitschrift Molecular Therapy, 2024. Verfasst von Fanglin Gong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada; Institute of Biomedical Engineering, University of Toronto, Toron…. Hauptthemen laut MEDLINE: Gene Editing, Liver, Genetic Vectors, Gene Transfer Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada.
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, ON M5S 3G9, Canada; Department of Chemistry, University of Toronto…
Zitieren
APA
Gong, F., & Li, B. (2024). Hybrid non-viral and viral delivery strategy achieves potent gene editing in growing livers with reduced viral dosage. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.08.021
Vancouver
Gong F, Li B. Hybrid non-viral and viral delivery strategy achieves potent gene editing in growing livers with reduced viral dosage. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.08.021
BibTeX
@article{Gong2024,
author = {Gong, Fanglin and Li, Bowen},
title = {Hybrid non-viral and viral delivery strategy achieves potent gene editing in growing livers with reduced viral dosage},
journal = {Molecular Therapy},
year = {2024},
doi = {10.1016/j.ymthe.2024.08.021}
}
EUVIMED